Get the app!
Back to Trades

Bradway Robert A

Chairman, CEO and President, DirectorCIK: 0001396482

Bradway Robert A, Chairman, CEO and President, Director, has filed 8 insider trading reports covering 2 companies. Total disclosed trading volume is $36.8M. Purchases and sales are approximately balanced over this period. The largest single filing involves AMGEN INC (AMGN). All transactions sourced from SEC Form 4 filings.

Total Volume
$36.8M
Purchases
$0
Sales
$0
Companies
2

Trading History (8 filings)

Bradway Robert AChairman, CEO and President, Director
Filed May 11, 2026
Other
$0
Bradway Robert AChairman, CEO and President, Director
Filed May 7, 2026
Grant
$0
1 grant
Bradway Robert AChairman, CEO and President, Director
Filed May 5, 2026
Other
$0
Bradway Robert AChairman, CEO and President, Director
Filed Mar 18, 2026
Other
$0
Bradway Robert AChairman, CEO and President, Director
Filed Mar 5, 2026
Grant
$0
1 grant